Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. defibrillation
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Defibrillation Articles & Analysis

33 news found

Global Safety Week | Zero Harm at Work and at Home

Global Safety Week | Zero Harm at Work and at Home

At Clarke Energy, we recognise that health and safety is crucial to our operations, particularly in the energy and engineering industry where risks are inherent. At our headquarters in the UK, we recently marked the fourth annual Global Safety Week, held from the 10th to the 14th of June 2024. With the theme “Zero Harm at Work and at Home,” this year’s event emphasised the ...

ByClarke Energy


EMI/RFI: Materials and Technologies - A Comprehensive Market Analysis by BCC Research

EMI/RFI: Materials and Technologies - A Comprehensive Market Analysis by BCC Research

Boston: “According to the latest BCC Research study, the demand for EMI/RFI: Materials and Technologies is estimated to increase from $7.4 billion in 2023 to reach $9.2 billion by 2028, at a compound annual growth rate (CAGR) of 4.6% from 2023 through 2028.” This comprehensive report delves into the dynamic landscape of the EMI/RFI materials and technologies market, meticulously ...

ByBCC Research


Implicity Joins the AWS ISV Accelerate Program

Implicity Joins the AWS ISV Accelerate Program

Implicity’s AI-powered* platform allows healthcare professionals to better manage the growing streams of patient information produced by cardiac implantable electronic devices (CIEDs), such as pacemakers and implanted defibrillators. The solutions can also interpret data and automatically alert care teams when intervention is required. ...

ByImplicity


Bayer to invest a total of 60 million euros in its Ukrainian seed production site

Bayer to invest a total of 60 million euros in its Ukrainian seed production site

Additionally, Bayer purchased six ambulances and 44 defibrillators for the Red Cross Ukraine. Throughout the war, Bayer has continued to pay employees their full salary and supports them with additional benefits such as monetary support, relocation, and sheltering. ...

ByBayer AG


Network of Automated External Defibrillators in Poland before the SARS-CoV-2 Pandemic: An In-Depth Analysis

Network of Automated External Defibrillators in Poland before the SARS-CoV-2 Pandemic: An In-Depth Analysis

Analyzing out-of-hospital cardiac arrest (OHCA) cases, one of the key components is automatic external defibrillators (AEDs). Aim: The aim of this study was to analyze the use and distribution of AEDs in Polish public places. ...

ByIntelesens Ltd


Location of out-of-hospital cardiac arrests and automated external defibrillators in relation to schools in an English ambulance service region

Location of out-of-hospital cardiac arrests and automated external defibrillators in relation to schools in an English ambulance service region

Introduction: This study sought to identify the availability of automated external defibrillators (AEDs) in schools in the region served by West Midlands Ambulance Service University NHS Trust (WMAS), United Kingdom, and the number of out-of-hospital cardiac arrests (OHCA) that occurred at or near to schools. A secondary aim was to explore the cost effectiveness of school-based ...

ByIntelesens Ltd


Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO

Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO

Jude Medical in 1997 as Vice President, Systems Development as part of the company’s acquisition of Ventritex, Inc., a startup implantable defibrillator company where he had worked since 1987. He went on to become Senior Vice President, Clinical/Regulatory Affairs for the St. ...

ByProcyrion, Inc.


Imricor Announces Development Agreement with MIPM

Imricor Announces Development Agreement with MIPM

(Company or Imricor) (ASX:IMR) the global leader in Realtime iCMR cardiac ablation products, is pleased to announce it has entered into a Development Agreement with Mammendorfer Institut für Physik und Medizin GmbH (MIPM), a leading developer and manufacturer of MRI-compatible medical devices, including an MRI-compatible external cardioverter defibrillator. MIPM is ...

ByImricor


EMS Safety Services Founders Paul and Marian Lepore Join Rithem Life Sciences’ Strategic Advisory Board

EMS Safety Services Founders Paul and Marian Lepore Join Rithem Life Sciences’ Strategic Advisory Board

EMS Safety Services, now part of the Health and Safety Institute (HSI) family of brands, is one of the nation’s largest CPR, automated external defibrillator (AED), and first aid training programs. The Strategic Advisory Board collaborates with Rithem’s leadership team as the company advances the development, sale, and distribution of its portable, hands-only CPR aid ...

ByRithem Life Sciences


CARMAT appoints Ivo Simundic as Sales director for the DACH region to support the deployment of the Aeson artificial heart in Germany, Austria and Switzerland

CARMAT appoints Ivo Simundic as Sales director for the DACH region to support the deployment of the Aeson artificial heart in Germany, Austria and Switzerland

Ivo started his career within the healthcare sector in 1999 at Medtronic as a Sales Engineer in Cardiac Rhythm Management for South-West Germany, before moving to the position of Area Sales manager for Automated External Defibrillators for the entire German market in 2007. From 2007 to 2011, he held several management positions at Philips Respironics (Sales Director Respiratory ...

ByCarmat


Orchestra BioMed Announces Peer-Reviewed Publication of MODERATO II Study Results Showing a Statistically Significant Reduction in Blood Pressure in Pacemaker-Indicated Patients Treated with BackBeat Cardiac Neuromodulation Therapy

Orchestra BioMed Announces Peer-Reviewed Publication of MODERATO II Study Results Showing a Statistically Significant Reduction in Blood Pressure in Pacemaker-Indicated Patients Treated with BackBeat Cardiac Neuromodulation Therapy

Longer-term follow up results from the MODERATO II study presented at the American College of Cardiology conference in May 2021, but not included in JAHA publication, showed that BackBeat CNT reduced oSBP in treated ISH patients by an average of 16.4 mmHg after 18 months of treatment. 1BIS Research, 2017, Global Pacemaker and Implantable Cardioverter Defibrillators (ICDs) Market ...

ByOrchestra BioMed, Inc.


Former Los Angeles County Sheriff Jim McDonnell Joins Rithem Life Sciences’ Strategic Advisory Board

Former Los Angeles County Sheriff Jim McDonnell Joins Rithem Life Sciences’ Strategic Advisory Board

McDonnell will aid in efforts to provide Rithem’s CPR aid and automated external defibrillator – JoltzAED – to police units across the country. The Strategic Advisory Board collaborates with Rithem’s leadership team as the company advances the development, sale, and distribution of its portable, comprehensive “high-quality” CPR aid – ...

ByRithem Life Sciences


Adagio Medical Announces First-In-Human Use and Initiation of Multi-Center Study of Ultra-Low Temperature Cryoablation for Treatment of Recurrent Ventricular Tachycardia, Opening New Possibilities for High-Risk Patients

Adagio Medical Announces First-In-Human Use and Initiation of Multi-Center Study of Ultra-Low Temperature Cryoablation for Treatment of Recurrent Ventricular Tachycardia, Opening New Possibilities for High-Risk Patients

” VT and ventricular fibrillation are important causes of sudden cardiac death, accounting for as many as 450,000 annual deaths in the US alone. Implantable cardiac defibrillators reduce the incidence of death in patients with arrhythmias, but are not curative, and can contribute to reduced quality of life in patients with recurring episodes. ...

ByAdagio Medical, Inc.


Rithem Life Sciences Announces Formation of Strategic Advisory Board

Rithem Life Sciences Announces Formation of Strategic Advisory Board

The Strategic Advisory Board will collaborate with Rithem’s leadership team as the company continues advancing the development of its portable, hands-only CPR aid – ResQR and the automated external defibrillator – JoltzAED. The ResQR is ergonomically designed with advanced features such as a placement indicator as well as metronome and LED light guidance to ...

ByRithem Life Sciences


Bluegrass Vascular Announces Publication Reporting Experience with Cardiac Resynchronization Therapy Device Lead Placement following Use of Surfacer System

Bluegrass Vascular Announces Publication Reporting Experience with Cardiac Resynchronization Therapy Device Lead Placement following Use of Surfacer System

For the present paper, the Surfacer System was utilized to gain central venous access which facilitated placement of three cardiac leads prior to the placement of an implantable CRT defibrillator in a patient with bilateral occluded brachiocephalic veins and an occluded superior vena cava. ...

ByBluegrass Vascular Technologies, Inc.


Rithem Life Sciences Announces Medical Advisory Board

Rithem Life Sciences Announces Medical Advisory Board

The Medical Advisory Board will collaborate with Rithem's leadership team as the company continues advancing the development of its portable, hands-only CPR aid – ResQR and the automated external defibrillator – JoltzAED. The ResQR is ergonomically designed with advanced features such as a placement indicator as well as metronome and LED light guidance to ensure ...

ByRithem Life Sciences


1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

Standard care in treating cardiac arrest involves chest compressions and defibrillation. This replaces about a third of the blood flow in the body and compressions prolong the life of a patient for about 30 minutes. ...

ByNeurescue


Professor Gust H. Bardy, M.D. of Bardy Diagnostics Partners with Arrhythmia Alliance to Increase Patient Awareness of Heart Arrhythmias and Early Detection

Professor Gust H. Bardy, M.D. of Bardy Diagnostics Partners with Arrhythmia Alliance to Increase Patient Awareness of Heart Arrhythmias and Early Detection

Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technological perspective. ...

ByBardy Diagnostics, Inc.


USPTO issues Patent for ground breaking polysaccharide technology platform to Endomedix.

USPTO issues Patent for ground breaking polysaccharide technology platform to Endomedix.

After neurosurgery, Endomedix plans to target hemostasis indications for cardiac pacemaker and implanted defibrillator procedures. As an example of the potential scope of the technology, Endomedix has recently entered into a Cooperative Research And Development Agreement (CRADA) with the US Army using PLEXimine to develop a treatment for Ocular Projectile Battlefield Trauma. ...

ByEndomedix, Inc.


Thermedical Scores Fda Breakthrough Designation For Ablation System To Treat Ventricular Tachycardia

Thermedical Scores Fda Breakthrough Designation For Ablation System To Treat Ventricular Tachycardia

Today, most people with VT are treated with implantable cardioverter defibrillators (ICDs), which monitor the heart rhythm and deliver a strong shock to the heart muscle to correct irregular pacing. ...

ByThermedical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT